Literature DB >> 25473687

[Current recommendations for the treatment of chronic hepatitis C].

Christoph Sarrazin, Thomas Berg, Peter Buggisch, Matthias Dollinger, Holger Hinrichsen, Dietrich Hüppe, Michael Manns, Stefan Mauss, Jörg Petersen, Karl-Georg Simon, Ingo van Thiel, Heiner Wedemeyer, Stefan Zeuzem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25473687

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN： 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  2 in total

1.  Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis.

Authors:  Ana Paula de Torres Santos; Vanessa Cristina Martins Silva; Maria Cássia Mendes-Corrêa; Marcilio Figueiredo Lemos; Fernanda de Mello Malta; Rúbia Anita Ferraz Santana; Gregório Tadeu Fernando Dastoli; Vanessa Fusco Duarte de Castro; João Renato Rebello Pinho; Regina Célia Moreira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-30       Impact factor: 2.169

2.  Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes.

Authors:  Vanessa D Costa; Carlos E Brandão-Mello; Estevão P Nunes; Pedro Guilherme Corôa Dos Santos Silva; Lia Laura Lewis Ximenez de Souza Rodrigues; Elisabeth Lampe; Francisco Campello do Amaral Mello
Journal:  PLoS One       Date:  2019-05-07       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.